HopeStage
Back to all studies
TerminatedNCT04634669

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Medication studyAges 18+United StatesDepression
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
Little Rock and 19 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 23, 2020
Recruitment status
Terminated
Enrollment listed in the registry
181
Sponsor
Axsome Therapeutics, Inc.
Sponsor type
Biotech company
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT04634669
Official title
Show the full official title

An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Treatment Resistant Depression

Recruitment & locations

Terminated

Little Rock · Redlands · Sherman Oaks

17 more locations
  • Upland
  • Miami
  • Miami Lakes
  • Orlando
  • Chicago
  • Boston
  • Berlin
  • Rochester
  • Staten Island
  • Hickory
  • Raleigh
  • Cincinnati
  • Middleburg Heights
  • Media
  • Dallas
  • Friendswood
  • Everett

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Axsome Therapeutics, Inc.

Does this study involve medication?

Yes. The study involves medication, including AXS-05 (dextromethorphan-bupropion).

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies